Loading
Molbio Diagnostics Stock: price and insider trades · India
IN·Mcap ₹166.6B
Molbio Diagnostics: what insiders have been doing
We have very little insider data for Molbio Diagnostics so far: the most recent filing dates from 30 September 2026. With so few records, no pattern can be drawn yet. Source: insider filings from SEBI (PIT + SAST). Past trades are no guide to future returns.
Insider Decl.
1
Thresholds
n/a
Buy Volume
n/a
n/a
Sell Volume
n/a
1 ops. · all time
Who traded when
BuySaleBusiness Excellence Trust III - India Business Excellence Fund III1 sale
Analyst consensus: bullish or bearish?
Analysts rate Molbio Diagnostics Strong Buy (bullish), based on 3 analysts. Average price target: ₹1,650.00.
Fundamental score
Ranked 13,533 of 24,166 companies
48.1
score / 100
Value25
Quality71
FCF yld0.0%
Earn yld0.9%
EV/EBITDA57.0x
ROE·
Gross mgn59%
Net mgn12%
Debt/EBITDA1.4x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Financial data
as of FY 2026FY ended March 2026 · cache
₹1,445.70
Analyst consensus
3 analystsStrong buy
₹1,550.00Target ₹1,650.00(+14%)₹1,800.00
Income statement
Revenue₹14.1B
Gross profit₹8.3B59% margin
EBITDA₹3.3B23% margin
Net income₹1.7B14.2% margin
Valuation
PER (trailing)99.4x
PER (forward)40.3x
P/Book13.9x
Balance sheet & cash
Market cap₹166.6B
Total debt₹4.5B
Free Cash Flow₹3.6M
Debt / Equity34%
Profitability & ownership
% insiders80.8%
% institutions5.2%
Last declaration on 30 September 2026
Declarations1 total
3,000,000 sharesEquity SharesSale of Shares - marketSEBI:18b4971a6faf4330da73f4dedf13b3c34e4fcf90
1 of 1 declaration
About Molbio Diagnostics
Molbio Diagnostics is a company focused on developing molecular diagnostic solutions. It specializes in innovative technologies for the screening of infectious diseases.
